This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carvalho, A. L. Articles by Califano, J. A. Search for Related Content PubMed PubMed Citation Articles by Carvalho, A. L. Articles by Califano, J. A.

Deleted in Colorectal Cancer Is a Putative Conditional Tumor-Suppressor Gene Inactivated by Promoter Hypermethylation in Head and Neck Squamous Cell Carcinoma

Departments of ¹ Otolaryngology-Head and Neck Surgery, ² Pathology, and ³ Dermatology, Johns Hopkins Medical Institutions, Baltimore, Maryland; and ⁴ Campus Bio-Medico University, Rome, Italy

Requests for reprints: Joseph A. Califano, Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Medical Institutions, 601 North Caroline Street, 6th Floor, Baltimore, MD 21287-0910. Phone: 410-502-5133; Fax: 1-410-614-1411; E-mail: jcalifa{at}jhmi.edu.

Deleted in colorectal cancer (DCC) is a candidate tumor-suppressor gene located at chromosome 18q21. However, DCC gene was found to have few somatic mutations and the heterozygous mice (DCC^+/–) showed a similar frequency of tumor formation compared with the wild-type mice (DCC^+/+). Recently, DCC came back to the spotlight as a better understating of its function and relationship with its ligand (netrin-1) had shown that DCC may act as a conditional tumor-suppressor gene. We evaluated hypermethylation as a mechanism for DCC inactivation in head and neck squamous cell carcinoma (HNSCC). DCC promoter region hypermethylation was found in 75% of primary HNSCC. There was a significant correlation between DCC promoter region hypermethylation and DCC expression (assessed by immunohistochemistry; P = 0.021). DCC nonexpressing HNSCC cell lines JHU-O12 and JHU-O19 with baseline hypermethylation of the DCC promoter were treated with 5-aza-2'-deoxycytidine (a demethylating agent) and reexpression of DCC was noted. Transfection of DCC into DCC-negative HNSCC cell lines resulted in complete abrogation of growth in all cell lines, whereas additional cotransfection of netrin-1 resulted in rescue of DCC-mediated growth inhibition. These results suggest that DCC is a putative conditional tumor-suppressor gene that is epigenetically inactivated by promoter hypermethylation in a majority of HNSCC. (Cancer Res 2006; 66(19): 9401-07)

This article has been cited by other articles:

				S. Derks, L. J.W. Bosch, H. E.C. Niessen, P. T.M. Moerkerk, S. M. van den Bosch, B. Carvalho, S. Mongera, J.W. Voncken, G. A. Meijer, A. P. de Bruine, et al. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21 Carcinogenesis, June 1, 2009; 30(6): 1041 - 1048. [Abstract] [Full Text] [PDF]

				C. Delloye-Bourgeois, E. Brambilla, M.-M. Coissieux, C. Guenebeaud, R. Pedeux, V. Firlej, F. Cabon, C. Brambilla, P. Mehlen, and A. Bernet Interference With Netrin-1 and Tumor Cell Death in Non-Small Cell Lung Cancer J Natl Cancer Inst, February 18, 2009; 101(4): 237 - 247. [Abstract] [Full Text] [PDF]

				J.-P. Roperch, K. El Ouadrani, A. Hendrix, S. Emami, O. De Wever, G. Melino, and C. Gespach Netrin-1 Induces Apoptosis in Human Cervical Tumor Cells via the TAp73{alpha} Tumor Suppressor Cancer Res., October 15, 2008; 68(20): 8231 - 8239. [Abstract] [Full Text] [PDF]